Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands

• Daniëla K. van Santen ,

  * E-mail: dvsanten@ggd.amsterdam.nl

  Affiliation Department of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Anneke S. de Vos,

  Affiliation Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands

  ⨯
• Amy Matser,

  Affiliation Department of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Sophie B. Willemse,

  Affiliation Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands

  ⨯
• Karen Lindenburg,

  Affiliation Department of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands

  ⨯
• Mirjam E. E. Kretzschmar,

  Affiliations Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands, National Institute of Public Health and the Environment, Bilthoven, the Netherlands

  ⨯
• Maria Prins,

  Affiliations Department of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands, Department of Infectious Diseases, Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, the Netherlands

  ⨯
• G. Ardine de Wit

  Affiliations Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands, National Institute of Public Health and the Environment, Bilthoven, the Netherlands

  ⨯